The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study
PLOS Medicine · 2023
DOI: 10.1371/journal.pmed.1004252 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, 2023. Verfasst von Allison Portnoy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Tuberculosis Vaccines. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Wellcome Trust, Medical Research Council, World Health Organization.
Abstract (Originalsprache)
Background
Most individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death impact economic productivity and burden health systems. New TB vaccine products may reduce this burden. In this study, we estimated the impact of introducing novel TB vaccines on gross domestic product (GDP) growth in 105 LMICs. Methods and findings We adapted an existing macroeconomic model to simulate country-level GDP trends between 2020 and 2080, comparing scenarios for introduction of hypothetical infant and adolescent/adult vaccines to a no-new-vaccine counterfactual. We parameterized each scenario using estimates of TB-related mortality, morbidity, and healthcare spending from linked epidemiological and costing models. We assumed vaccines would be introduced between 2028 and 2047 and estimated incremental changes in GDP within each country from introduction to 2080, in 2020 US dollars. We tested the robustness of results to alternative analytic specifications. Both vaccine scenarios produced greater cumulative GDP in the modeled countries over the study period, equivalent to $1.6 (95% uncertainty interval: $0.8, 3.0) trillion for the adolescent/adult vaccine and $0.2 ($0.1, 0.4) trillion for the infant vaccine. These GDP gains were substantially lagged relative to the time of vaccine introduction, particularly for the infant vaccine. GDP gains resulting from vaccine introduction were concentrated in countries with higher current TB incidence and earlier vaccine introduction. Results were sensitive to secular trends in GDP growth but relatively robust to other analytic assumptions. Uncertain projections of GDP could alter these projections and affect the conclusions drawn by this analysis.
Conclusions
Under a range of assumptions, introducing novel TB vaccines would increase economic growth in LMICs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America.
- Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
- Department of International Economics, The Graduate Institute of International and Development Studies, Geneva, Switzerland.
- Fondation pour les études et recherches sur le développement international (FERDI), Clermont-Ferrand, France.
- Global Development Network, New Delhi, India.
- Université Mohammed VI Polytechnique, Rabat, Morocco.
ORCID-Profile: Allison Portnoy, Rebecca A Clark, Roel Bakker, Mark Jit, Richard G White
Förderung
- Wellcome Trust
- Medical Research Council
- World Health Organization
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
- Canadian Centennial Scholarship Fund
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- European and Developing Countries Clinical Trials Partnership
Zitieren
APA
Portnoy, A., Arcand, J. L., Clark, R. A., Weerasuriya, C. K., Mukandavire, C., Bakker, R., Patouillard, E., Gebreselassie, N., Zignol, M., Jit, M., White, R. G., & Menzies, N. A. (2023). The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004252
Vancouver
Portnoy A, Arcand JL, Clark RA, Weerasuriya CK, Mukandavire C, Bakker R, et al. The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. PLOS Medicine. 2023. doi:10.1371/journal.pmed.1004252
BibTeX
@article{Portnoy2023,
author = {Portnoy, Allison and Arcand, Jean-Louis and Clark, Rebecca A and Weerasuriya, Chathika K and Mukandavire, Christinah and Bakker, Roel and Patouillard, Edith and Gebreselassie, Nebiat and Zignol, Matteo and Jit, Mark and White, Richard G and Menzies, Nicolas A},
title = {The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study},
journal = {PLOS Medicine},
year = {2023},
doi = {10.1371/journal.pmed.1004252}
}
EUVIMED